<DOC>
	<DOCNO>NCT02483611</DOCNO>
	<brief_summary>The magnesium sulfate lidocaine increasingly use alone combination anesthesia procedure meet various objective , reduction pain , use small anesthetic dos stabilization hemodynamic parameter . These medicine often use combination neuromuscular block agent , may contribute occurrence residual block patient anesthetic procedure . It estimate 1-3 % patient residual block develop clinically apparent event . In small proportion patient , consequence residual blockade serious even lethal . It estimate 40 % patient muscle paralysis come post-anesthesia care unit ( PACU ) . Considering : ( ) magnesium sulfate lidocaine show increase number application various area medicine , ( b ) medication stand property analgesic , anti-inflammatory , anti-arrhythmic , neuroprotective capable reduce demand anesthetic opioids , ( c ) magnesium sulfate lidocaine important part therapeutic arsenal control large number disease ( ) patient surgical surgery potentially benefit particular effect , ( ) drug use routinely many medical service well adjuvant anesthesia , ( f ) previous study show magnesium sulfate able prolong duration neuromuscular blockade different type muscle relaxant , controversy effect latency ( g ) effect lidocaine action muscle relaxant current literature show great controversy ( h ) exist literature study involve drug ; investigator aim investigate effect magnesium sulphate infuse alone associate lidocaine neuromuscular blockade promote cisatracurium , well evaluate possible hemodynamic repercussion . For purpose SM infuse bolus , prior tracheal intubation continuously maintenance general anesthesia ; Lidocaine , associate Isotonic Solution use way timeline SM . As secondary objective propose evaluate Lidocaine Magnesium Sulfate would able interfere hemodynamic stability patient study .</brief_summary>
	<brief_title>Effects Intravenous Lidocaine Associated With Magnesium Sulfate Cisatracurium-Induced Neuromuscular Block</brief_title>
	<detailed_description>The study approve Medical Research Ethics Committee Hospital das Clinicas , Faculty Medicine Ribeirao Preto , University Sao Paulo , Brazil ; Its Unique Protocol ID 5362/2013 . This study conduct free write informed consent study subject . This report describe prospective randomize clinical trial . The author state report include every item checklist prospective randomize clinical trial . The study register prior patient enrollment . Forty‐eight American Society Anesthesiology patient classification status ASA I II undergo elective surgery divide three parallel group . The M group receive MS 40 mg.kg-1 bolus induction anesthesia 20mg.kg-1h-1 via continuous i.v . infusion operation period . The ML group receive identical dos MS combine lidocaine 3 mg.kg-1 bolus induction anesthesia 3 mg.kg-1h-1 via continuous i.v . infusion operation period . The control group administer equivalent volume isotonic solution . Anesthesia maintain via propofol remifentanil infusion . After loss patient consciousness administration bolus infusion , 0.15 mg.kg-1 bolus cisatracurium administer patient 5 s. No additional cisatracurium injection perform . The patient 's neuromuscular function assess every 15 measure adductor polis TOF Watch SX acceleromyograph . The primary endpoint time spontaneous recovery train-of-four ( TOF ) ratio 90 % achieve . The systolic , diastolic mean heart rate record annotate various time : M1- patient arrive operating room ; M2- immediately induction anesthesia ; M3- infusion test solution ( saline , magnesium sulphate magnesium sulphate associate lidocaine ) ; M4- five minute M3 ( end infusion load dose test solution ) ; M5 immediately intubation ; M6- one minute tracheal intubation M7 ( f ) - every fifteen minute end study . The sample size calculate power 80 % detect differences 20 % time clinical onset duration neuromuscular blockade ( NMB ) . Quantitative variable describe mean ± standard deviation . The normality distribution test variable group , use non-parametric test Shapiro-Wilk . When variable normally distribute , use analysis variance test ( ANOVA ) comparison group . When difference find group , use Tukey test multiple comparison . When variable normally distribute apply Shapiro-Wilk test , use Kruskal-Wallis test compare group . When difference find group , use Dunn test multiple comparison . The critical level significance 5 % . During analysis recovery characteristic neuromuscular blockade , parameter base T1 response ( DUR 25 % DUR 75 % DUR 95 % ) normalize consider final T1 value response return baseline ( VIBY-MOGENSEN et al. , 1996 ) .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<criteria>Before recruitment patient , study approve Brazil Platform ( national unify basis research involve human subject record ) publish ClinicalTrials.gov ASA I II BMI 18 29 Use medication could affect neuromuscular blockade calcium channel inhibitor , anticonvulsant lithium carbonate Presence neuromuscular , renal hepatic dysfunction . Hypermetabolic hypometabolic state fever , infection , hyperthyroidism hypothyroidism Acidbase disorder , congestive heart failure conductive heart problem , treat cardiac arrhythmia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Onset</keyword>
	<keyword>Recovery</keyword>
	<keyword>Lidocaine</keyword>
	<keyword>Cisatracurium</keyword>
	<keyword>Magnesium sulfate</keyword>
	<keyword>Isotonic solution</keyword>
</DOC>